Blackrock Neurotech (formerly Blackrock Microsystems) is the manufacturer of the Utah Array, the most widely used intracortical electrode platform in human BCI research. The company supplies research-grade neural recording and stimulation systems to academic labs worldwide and holds multiple FDA IDEs for clinical use of the Utah Array in paralysis and epilepsy monitoring. Blackrock was briefly acquired by ONWARD Medical but subsequently returned to independent operation under Marcus Gerhardt. The company also develops the MoveAgain closed-loop system for spinal cord injury rehabilitation.